Literature DB >> 16628579

Locally acquired hepatitis E virus infection, El Paso, Texas.

Joseph J Amon1, Jan Drobeniuc, William A Bower, Jorge C Magaña, Miguel A Escobedo, Ian T Williams, Beth P Bell, Gregory L Armstrong.   

Abstract

Hepatitis E virus (HEV) is an enterically transmitted RNA virus that causes both epidemic and sporadic cases of acute hepatitis. Despite sero-surveys showing antibody to HEV in up to 36% of the US population, acute hepatitis E has been reported among individuals with no history of international travel only three times in the United States. We report a case of apparently locally-acquired hepatitis E that occurred in El Paso, Texas that was 98% similar to a previously isolated HEV found in swine in the United States. Like the three previous cases, a thorough investigation found no conclusive sources of infection. Active case surveillance found no additional cases.

Entities:  

Mesh:

Year:  2006        PMID: 16628579     DOI: 10.1002/jmv.20617

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.

Authors:  Xinjie Wang; Qin Zhao; Lu Dang; Yani Sun; Jiming Gao; Baoyuan Liu; Shahid Faraz Syed; Hu Tao; Gaiping Zhang; Jianxun Luo; En-Min Zhou
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  Acute hepatitis E virus infection in an HIV-infected person in the United States.

Authors:  Jennifer A Curry; Nehkonti Adams; Nancy F Crum-Cianflone
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

3.  Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A.

Authors:  H R Dalton; W Stableforth; S Hazeldine; P Thurairajah; R Ramnarace; U Warshow; S Ijaz; V Ellis; R Bendall
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

4.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

5.  Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mark H Kuniholm; Robert H Purcell; Geraldine M McQuillan; Ronald E Engle; Annemarie Wasley; Kenrad E Nelson
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

Review 6.  Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection.

Authors:  Harini Sooryanarain; Xiang-Jin Meng
Journal:  Virus Res       Date:  2020-04-23       Impact factor: 3.303

Review 7.  Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States.

Authors:  Megan G Hofmeister; Monique A Foster; Eyasu H Teshale
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

8.  Profile of acute infectious markers in sporadic hepatitis E.

Authors:  Shoujie Huang; Xuefeng Zhang; Hanmin Jiang; Qiang Yan; Xing Ai; Yijun Wang; Jiaping Cai; Lang Jiang; Ting Wu; Zhongze Wang; Li Guan; J Wai Kuo Shih; Mun-Hon Ng; Fengcai Zhu; Jun Zhang; Ningshao Xia
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

9.  Hepatitis E: a complex and global disease.

Authors:  E Pelosi; I Clarke
Journal:  Emerg Health Threats J       Date:  2008-11-07

10.  Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012.

Authors:  Jan Drobeniuc; Tracy Greene-Montfort; Ngoc-Thao Le; Tonya R Mixson-Hayden; Lilia Ganova-Raeva; Chen Dong; Ryan T Novak; Umid M Sharapov; Rania A Tohme; Eyasu Teshale; Saleem Kamili; Chong-Gee Teo
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.